多巴酚丁胺对脓毒症心肌功能障碍大鼠内在心肌功能与心肌损伤的长期影响
该研究在大鼠盲肠结扎穿孔(CLP)脓毒症模型中观察多巴酚丁胺的长期效应。CLP后6小时左心室±dP/dt显著降低、心肌TNF-α与VCAM-1表达升高,但血清cTnI、NT-proBNP、H-FABP、肌酐和尿素氮未升高;CLP后9小时出现肝功能障碍。CLP后6小时给予多巴酚丁胺(10.0 μg/kg)未影响血流动力学、左心室±dP/dt、血清与心肌细胞因子水平,也未改善CLP后20小时的心肌细胞凋亡和心脏血管高通透性,但提高血清IL-10水平并改善脓毒症大鼠生存。提示内在心肌抑制早于肝肾功能障碍,血清cTnI、NT-proBNP、H-FABP不适合作为脓毒症心肌功能障碍的早期生物标志物。
要点
- 脓毒症大鼠CLP后6小时左心室±dP/dt显著降低,早于CLP后9小时出现的肝功能障碍。
- CLP后6小时血清cTnI、NT-proBNP、H-FABP、肌酐、尿素氮未升高,这些指标不适合作为早期生物标志物。
- CLP后6小时给予多巴酚丁胺10.0 μg/kg未改善CLP后20小时的心肌细胞凋亡和心脏血管高通透性。
- 多巴酚丁胺10.0 μg/kg提高血清IL-10水平并改善脓毒症大鼠生存。
- 多巴酚丁胺未改善脓毒症后期的心肌功能、血流动力学或心肌损伤。
适用人群与场景
- 盲肠结扎穿孔(CLP)脓毒症大鼠模型,存在心肌功能障碍(CLP后6小时左心室±dP/dt显著降低)。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- CLP后6小时给予多巴酚丁胺10.0 μg/kg(原文未提及给药途径和频次),未改善CLP后20小时的心肌细胞凋亡和心脏血管高通透性,但提高血清IL-10水平并改善生存。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为动物实验(大鼠CLP脓毒症模型),样本量与中心数原文未提及;CLP后6小时左心室±dP/dt显著降低、心肌TNF-α和VCAM-1表达增加,但血清cTnI、NT-proBNP、H-FABP、肌酐、尿素氮未升高;CLP后9小时出现肝功能障碍;CLP后6小时给予多巴酚丁胺10.0 μg/kg未影响血流动力学、左心室±dP/dt、血清和心肌细胞因子水平,未改善CLP后20小时心肌细胞凋亡和心脏血管高通透性,但提高血清IL-10水平并
证据类型、等级与局限
- 证据类型为动物实验(大鼠模型);原文未给出证据等级或推荐强度;局限包括动物模型、样本量未提及、单中心(原文未提及多中心)、结果需临床验证。
对床旁实践的改变
- 提示在脓毒症心肌功能障碍中,多巴酚丁胺虽可能改善生存,但不改善心肌功能、血流动力学或心肌损伤;血清cTnI、NT-proBNP、H-FABP不适合作为早期生物标志物;该结果来自大鼠模型,不能直接改变临床实践,需进一步临床研究验证。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Dobutamine (DOB) is recommended as an inotrope for septic patients with low cardiac output, but its long-term impact on sepsis-induced cardiomyopathy remains unclear. This study investigated the long-term effect of DOB on septic myocardial dysfunction and injury. Rats were exposed to cecal ligation and puncture (CLP), the intrinsic myocardial function, other organ functions, hemodynamics, inflammatory response, serum myocardial injury biomarkers, myocardial apoptosis, and vascular permeability were determined. At 6 h after CLP, the left ventricular ±dP/dt were significantly depressed, cardiac tumor necrosis factor-α and vascular cell adhesion molecule-1 expression were increased, but not serum cardiac troponin I (cTnI), N-terminal pro-brain natriuretic peptide (NT-proBNP), heart-type fatty acid-binding protein (H-FABP), creatinine, and urea nitrogen concentrations in CLP group compared with controls. At 9 h after CLP, hepatic dysfunction was present in CLP rats compared with controls. At 6 h after CLP, DOB treatment did not affect hemodynamics, the left ventricular ±dP/dt, cytokine levels in serum and myocardium, as well as cardiomyocyte apoptosis and cardiac vascular hyperpermeability at 20 h after CLP. However, DOB (10.0 μg/kg) increased serum IL-10 level and improved survival in septic rats. These results indicate that the intrinsic myocardial depression occurs earlier than hepatic and renal dysfunction in sepsis and serum cTnI, NT-proBNP, and H-FABP are not suitable as early biomarkers for sepsis-induced myocardial dysfunction. Although DOB treatment (10.0 μg/kg) in the presence of myocardial dysfunction improves survival in septic rats, it neither improves myocardial function and hemodynamics nor attenuates myocardial injury at the later stage of sepsis.
参考来源
- Tang X, Xu Y, Dai X, et al. The Long-term Effect of Dobutamine on Intrinsic Myocardial Function and Myocardial Injury in Septic Rats with Myocardial Dysfunction. Shock. 2021. PMID: 34524268. doi:10.1097/SHK.0000000000001718
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。